Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Gene

CTNNB1

2 articles · Resources: NCBI Gene, OncoKB

Clinical · Molecular biology

DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression

Merk DJ, Paßlack P, Surender S, et al.

Nature communications

This study investigates epigenomic variations as drivers of clinical heterogeneity and progression in meningiomas. Using global DNA methylation profiling on large cohorts, researchers identified a hypermethylation signature correlated with clinical outcomes, providing more accurate prognostication. Longitudinal analysis revealed convergent contributions but differing plasticity of copy number variations and DNA hypermethylation. Furthermore, the study uncovered a tumor suppressive role for clustered protocadherins, which restrict β-catenin nuclear localization, a factor associated with meningioma progression.

Clinical · Molecular biology

Profiling of desmoid tumors reveals frequent mutations in chromatin-remodeling genes and identifies an Immune-myogenic subtype

Gantzer J, Lu X, Weingertner N, et al.

European journal of cancer (Oxford, England

This study performed integrated genomic, transcriptomic, and DNA methylation profiling on 76 desmoid tumors (DTs), uncovering frequent mutations in chromatin-remodeling genes, notably KMT2C, in addition to the known CTNNB1 and APC mutations. Transcriptomic analysis identified two robust molecular subtypes: immune-myogenic and mesenchymal-like. The immune-myogenic subtype exhibited high expression of myogenic markers and immune checkpoint genes, alongside enhancer hypomethylation. This subtype is associated with increased immune cell infiltration and predicts a higher responsiveness to immune checkpoint inhibitors.